The 6-m timed hop test is a prognostic factor for outcomes in patients with meniscal tears treated with exercise therapy or arthroscopic partial meniscectomy: a secondary, exploratory analysis of the Odense-Oslo meniscectomy versus exercise (OMEX) trial.

6-m timed hop test Arthroscopic partial meniscectomy Degenerative meniscal lesions Degenerative meniscal tears Exercise therapy Lower extremity performance Middle aged Prognostic factors

Journal

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
ISSN: 1433-7347
Titre abrégé: Knee Surg Sports Traumatol Arthrosc
Pays: Germany
ID NLM: 9314730

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 23 03 2018
accepted: 17 10 2018
pubmed: 18 11 2018
medline: 16 11 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

To identify the prognostic factors for 2-year patient-reported outcomes in middle-aged patients with degenerative meniscal tears treated with exercise therapy (ET) or arthroscopic partial meniscectomy (APM). One hundred and seven patients, with mean age 49.6 (SD 6.2) years and BMI 25.7 (SD 3.7), were included in this analysis of data from the OMEX trial ( http://www.clinicaltrials.gov NCT01002794). Linear and Poisson regression models were built to explore the associations between potential prognostic factors (patient characteristics, knee function-related and disease-related factors) and 2-year patient-reported outcomes: the Knee Injury and Osteoarthritis Outcome Score (KOOS) subscales Pain, Symptoms, ADL, Sport/Rec, QoL and 5-point Global Rating of Change scales for knee pain (GRC Pain) and function (GRC Function). Analyses were performed for the whole cohort and for the two treatment groups (n = 55 and 52) with adjustments for age, sex, BMI and baseline KOOS. For the whole cohort, a 1-s better baseline 6-m timed hop test result was associated with 3.1-7.1 points better 2-year scores for all KOOS subscales (95% CIs 1.1-5.2 to 4.1-10.1 points). A 1.61-2.80 s better test was associated with scores equivalent to previously calculated clinical relevant differences for each KOOS subscale. For the groups of patients treated with ET and APM, respectively, 2.09-3.60 s and 0.63-1.99 s better tests were associated with clinical relevant differences. For the whole cohort, a 1-s better test was associated with 26% (95% CI 15-38%) and 22% (95% CI 11-34%) higher possibility for better or much better GRC Pain and Function scores. Patients treated with ET had 17% (95% CI 2-33%) increased possibility for better or much better GRC Pain score, and patients treated with APM had 65% (95% CI 32-108%) and 70% (95% CI 38-109%) increased possibility for better or much better GRC Pain and Function scores. The 6-m timed hop test result was a significant prognostic factor for 2-year patient-reported outcomes in middle-aged patients with degenerative meniscal tears, especially in those treated with APM. II.

Identifiants

pubmed: 30446783
doi: 10.1007/s00167-018-5241-7
pii: 10.1007/s00167-018-5241-7
doi:

Banques de données

ClinicalTrials.gov
['NCT01002794']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

2478-2487

Références

J Clin Epidemiol. 2001 Apr;54(4):343-9
pubmed: 11297884
J Strength Cond Res. 2002 Nov;16(4):617-22
pubmed: 12423195
Arthritis Rheum. 2003 Aug;48(8):2178-87
pubmed: 12905471
Ann Rheum Dis. 1957 Dec;16(4):494-502
pubmed: 13498604
Eur J Appl Physiol. 2004 Jan;91(1):22-9
pubmed: 14508689
Health Qual Life Outcomes. 2003 Nov 03;1:64
pubmed: 14613558
Osteoarthritis Cartilage. 2004 Mar;12(3):177-90
pubmed: 14972335
Ann Rheum Dis. 2004 Apr;63(4):402-7
pubmed: 15020334
Ann Rheum Dis. 2007 Jan;66(1):18-22
pubmed: 17158140
Knee Surg Sports Traumatol Arthrosc. 2007 Apr;15(4):393-401
pubmed: 17216272
Scand J Med Sci Sports. 2007 Apr;17(2):120-7
pubmed: 17394472
Ann Rheum Dis. 2008 Jul;67(7):1034-6
pubmed: 18198197
Scand J Public Health. 2008 Jan;36(1):52-61
pubmed: 18426785
BMC Med Res Methodol. 2008 Oct 30;8:70
pubmed: 18973665
Am J Sports Med. 2011 May;39(5):926-32
pubmed: 21411745
Epidemiology. 2011 Sep;22(5):745
pubmed: 21811114
Knee Surg Sports Traumatol Arthrosc. 2013 Feb;21(2):358-64
pubmed: 22437659
J Orthop Sports Phys Ther. 2012 Nov;42(11):919-31
pubmed: 22960783
Osteoarthritis Cartilage. 2013 Mar;21(3):419-27
pubmed: 23220556
Br J Sports Med. 2014 May;48(9):784-8
pubmed: 23242961
N Engl J Med. 2013 May 2;368(18):1675-84
pubmed: 23506518
Am J Sports Med. 2013 Jul;41(7):1565-70
pubmed: 23703915
Am J Sports Med. 2013 Jun;41(6):1238-44
pubmed: 23733830
Osteoarthritis Cartilage. 2013 Oct;21(10):1558-66
pubmed: 23831632
Ann Rheum Dis. 2014 Dec;73(12):2116-21
pubmed: 23962456
N Engl J Med. 2013 Dec 26;369(26):2515-24
pubmed: 24369076
Lancet. 2014 Jan 11;383(9912):101-4
pubmed: 24411643
Osteoarthritis Cartilage. 2014 Nov;22(11):1808-16
pubmed: 25086401
CMAJ. 2014 Oct 7;186(14):1057-64
pubmed: 25157057
Arthroscopy. 2014 Nov;30(11):1424-9
pubmed: 25209166
Osteoarthritis Cartilage. 2015 Feb;23(2):171-7
pubmed: 25450853
Acta Orthop. 2016 Feb;87(1):5-11
pubmed: 26122621
Br J Sports Med. 2015 Oct;49(19):1229-35
pubmed: 26383759
J Sci Med Sport. 2016 Dec;19(12):990-998
pubmed: 27129638
BMJ. 2016 Jul 20;354:i3740
pubmed: 27440192
Am J Sports Med. 2017 Jul;45(9):2077-2084
pubmed: 28429967
Ann Rheum Dis. 2018 Feb;77(2):188-195
pubmed: 28522452
Orthop J Sports Med. 2017 Nov 14;5(11):2325967117739811
pubmed: 29164167
J Orthop Sports Phys Ther. 1997 Sep;26(3):138-42
pubmed: 9276854
Scand J Med Sci Sports. 1998 Dec;8(6):439-48
pubmed: 9863983

Auteurs

Nina Jullum Kise (NJ)

Orthopaedic Department, Martina Hansens Hospital, PO-box 823, 1306, Sandvika, Norway. nina.kise@mhh.no.

Ewa M Roos (EM)

Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, 5230, Odense M, Denmark.

Silje Stensrud (S)

OsloMet, Oslo Metropolitan University, PO-box 4, St.Olavs Plass, 0130, Oslo, Norway.

Lars Engebretsen (L)

Oslo University Hospital and University of Oslo, The Norwegian School of Sports Sciences, Oslo, Norway.

May Arna Risberg (MA)

Division of Orthopedic Surgery, Department of Sports Medicine, Oslo University Hospital, The Norwegian School of Sport Sciences, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH